CFT8634, a potent, selective and orally bioavailable BiDACTM degrader of BRD9, highlights the potential of C4T’S TORPEDO® platform to develop degraders with excellent drug-like properties against currently undruggable targets
Titel:
CFT8634, a potent, selective and orally bioavailable BiDACTM degrader of BRD9, highlights the potential of C4T’S TORPEDO® platform to develop degraders with excellent drug-like properties against currently undruggable targets
Auteur:
Chaturvedi, Prasoon Jackson, Katrina Agafonov, Roman He, Minsheng Nasveschuk, Christopher Kirby, Jason Poling, Laura Pollock, Roy Hurh, Eunju Reynolds, Joseph Reyno, Len Fisher, Stewart